Dive L, Newson AJ. Ethical issues in reproductive genetic carrier screening. Med J Aust. 2021;214:165–7.
Antonarakis SE. Carrier screening for recessive disorders. Nat Rev Genet. 2019;20:549–61.
Langlois S, Benn P, Wilkins-Haug L. Current controversies in prenatal diagnosis 4: pre-conception expanded carrier screening should replace all current prenatal screening for specific single gene disorders. Prenat Diagn. 2015;35:23–8.
Kraft SA, Duenas D, Wilfond BS, Goddard KAB. The evolving landscape of expanded carrier screening: challenges and opportunities. Genet Med J Am Coll Med Genet. 2019;21:790–7.
Schneider JL, Goddard KAB, Davis J, Wilfond B, Kauffman TL, Reiss JA, et al. Is it worth knowing? focus group participants’ perceived utility of genomic preconception carrier screening. J Genet Couns. 2016;25:135–45.
Kumar P, Radhakrishnan J, Chowdhary MA, Giampietro PF. Prevalence and patterns of presentation of genetic disorders in a pediatric emergency department. Mayo Clin Proc. 2001;76:777–83.
Fridman H, Yntema HG, Mägi R, Andreson R, Metspalu A, Mezzavila M, et al. The landscape of autosomal-recessive pathogenic variants in European populations reveals phenotype-specific effects. Am J Hum Genet. 2021;108:608–19.
van der Hout S, Dondorp W, de Wert G. The aims of expanded universal carrier screening: autonomy, prevention, and responsible parenthood. Bioethics 2019;33:568–76.
Delatycki MB, Alkuraya F, Archibald A, Castellani C, Cornel M, Grody WW, et al. International perspectives on the implementation of reproductive carrier screening. Prenat Diagn. 2020;40:301–10.
Silver J, Norton ME. Expanded carrier screening and the complexity of implementation. Obstet Gynecol. 2021;137:345–50.
Andermann A, Blancquaert I, Déry V. Genetic screening: a conceptual framework for programs and policy-making. J Health Serv Res Policy. 2010;15:90–7.
Gregg AR, Aarabi M, Klugman S, Leach NT, Bashford MT, Goldwaser T, et al. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med J Am Coll Med Genet 2021;23:1793–806.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.
Hawker S, Payne S, Kerr C, Hardey M, Powell J. Appraising the evidence: reviewing disparate data systematically. Qual Health Res. 2002;12:1284–99.
Thompson J, Vogel Postula K, Wong K, Spencer S. Prenatal genetic counselors’ practices and confidence level when counseling on cancer risk identified on expanded carrier screening. J Genet Couns. 2019;28:908–14.
Arjunan A, Bellerose H, Torres R, Ben-Shachar R, Hoffman JD, Angle B, et al. Evaluation and classification of severity for 176 genes on an expanded carrier screening panel. Prenat Diagn. 2020;40:1246–57.
Janssens S, Chokoshvili D, Vears D, De Paepe A, Borry P. Attitudes of European geneticists regarding expanded carrier screening. J Obstet Gynecol Neonatal Nurs Jognn. 2017;46:63–71.
Benn P, Chapman AR, Erickson K, Defrancesco MS, Wilkins-Haug L, Egan JFX, et al. Obstetricians and gynecologists’ practice and opinions of expanded carrier testing and noninvasive prenatal testing. Prenat Diagn. 2014;34:145–52.
Janssens S, Chokoshvili D, Vears DF, De Paepe A, Borry P. Pre- and post-testing counseling considerations for the provision of expanded carrier screening: exploration of European geneticists’ views. BMC Med Ethics. 2017;18:46.
Cho D, McGowan ML, Metcalfe J, Sharp RR. Expanded carrier screening in reproductive healthcare: perspectives from genetics professionals. Hum Reprod Oxf Engl 2013;28:1725–30.
Holtkamp KCA, Vos EM, Rigter T, Lakeman P, Henneman L, Cornel MC. Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscape. BMC Health Serv Res. 2017;17:146. 16.
Matar A, Kihlbom U, Höglund AT. Swedish healthcare providers’ perceptions of preconception expanded carrier screening (ECS)-a qualitative study. J Community Genet. 2016;7:203–14.
Schuurmans J, Birnie E, van den Heuvel LM, Plantinga M, Lucassen A, van der Kolk DM, et al. Feasibility of couple-based expanded carrier screening offered by general practitioners. Eur J Hum Genet Ejhg. 2019;27:691–700.
Stark Z, Massie J, McClaren B, Ioannou L, Cousens N, Lewis S, et al. Current practice and attitudes of Australian obstetricians toward population-based carrier screening for inherited conditions. Twin Res Hum Genet J Int Soc Twin Stud. 2013;16:601–7.
Molster CM, Lister K, Metternick-Jones S, Baynam G, Clarke AJ, Straub V, et al. Outcomes of an international workshop on preconception expanded carrier screening: some considerations for governments. Front Public Health. 2017;5:25.
Lazarin GA, Detweiler S, Nazareth SB, Ashkinadze E. Genetic counselors’ perspectives and practices regarding expanded carrier screening after initial clinical availability. J Genet Couns. 2016;25:395–404.
Matar A, Hansson MG, Höglund AT. Values and value conflicts in implementation and use of preconception expanded carrier screening – an expert interview study. BMC Med Ethics. 2019;20:25.
Ready K, Haque IS, Srinivasan BS, Marshall JR. Knowledge and attitudes regarding expanded genetic carrier screening among women’s healthcare providers. Fertil Sterile. 2012;97:407–13.
Matar A, Hansson MG, Höglund AT. “A perfect society” – Swedish policymakers’ ethical and social views on preconception expanded carrier screening. J Community Genet. 2019;10:267–80.
Briggs A, Nouri PK, Galloway M, O’Leary K, Pereira N, Lindheim SR. Expanded carrier screening: a current survey of physician utilization and attitudes. J Assist Reprod Genet. 2018;35:1631–40.
Chokoshvili D, Janssens S, Vears D, Borry P. Designing expanded carrier screening panels: results of a qualitative study with European geneticists. Pers Med. 2016;13:553–62.
Best S, Long J, Theodorou T, Hatem S, Lake R, Archibald A, et al. Health practitioners’ perceptions of the barriers and enablers to the implementation of reproductive genetic carrier screening: A systematic review. Prenat Diagn. 2021;41:708–19.
Committee Opinion No. 690. Carrier Screening in the Age of Genomic Medicine. Obstet Gynecol. 2017;129:e35–40.
Henneman L, Borry P, Chokoshvili D, Cornel MC, van El CG, Forzano F, et al. Responsible implementation of expanded carrier screening. Eur J Hum Genet EJHG. 2016;24:e1–12.
Ong R, Edwards S, Howting D, Kamien B, Harrop K, Ravenscroft G, et al. Study protocol of a multicentre cohort pilot study implementing an expanded preconception carrier-screening program in metropolitan and regional Western Australia. BMJOpen. 2019;9:e028209.
Rapport F, Clay-Williams R, Churruca K, Shih P, Hogden A, Braithwaite J. The struggle of translating science into action: Foundational concepts of implementation science. J Eval Clin Prof. 2018;24:117–26.